Remove Consulting Remove Individual Remove Manufacturing Remove Provider
article thumbnail

How to Get Ozempic & GLP-1’s Covered by Insurance (or Save Big with Plum Health Direct Primary Care): The Ultimate Guide You Can’t Afford to Miss!

Plum Health

Update: Click here to book a free 30 minute in-person consultation with Dr. Sharon or Dr. Mike to discuss affordable GLP-1 medication! If you have commercial insurance, you may be eligible to pay as little as $25 for Ozempic using a savings card from the manufacturer. Save with patient assistance programs.

article thumbnail

The Rising Tide of Medical Waste: One Model for Improvement

My Green Doctor

The breadth of services provided by modern day medicine is profound. Video recordings were taken as providers administered perioperative routine eyedrops to patients and the eyedrop bottle tips were cultured to assess microbial growth. The product manufacturers and vendors will need to be active partners as well. Cavanagh, D.,

Medical 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How Gut Health and Digestion Influence Cholesterol Levels

Imperial Center Family Medicine

The liver manufactures new cholesterol molecules and captures excess from circulation for excretion. Nonetheless, actively cultivating specialized cholesterol-absorbing bacteria provides another route for reducing high blood cholesterol. Contact us today at 919-873-4437 or online to book a consultation.

article thumbnail

Green Practice News: May 2025

My Green Doctor

Our Consulting Services offer customized strategies for group practices, health systems, and medical societies ready to accelerate their impact and lead the way in climate-smart care. Visit our website to explore membership options, start a Practice Management program, or speak with us about our Consulting Services.

article thumbnail

Warning Letters: An Untapped Source for Understanding When Device Changes Require a New 510(k)

FDA Law

Manufacturers must evaluate device changes in the first instance to determine whether a new 510(k) is needed or, instead, whether documentation of the change and rationale for not seeking 510(k) clearance is sufficient. Such assessments are highly individualized and difficult to map onto the few examples provided by FDA in its guidance.

article thumbnail

Price Limits, Affordability Boards, Penalties, Oh My: Minnesota Enacts Sweeping Drug Pricing Reforms

FDA Law

Kirschenbaum — On May 24, Minnesota enacted the Commerce and Consumer Protection Omnibus Bill, Senate File 2744 ( SF 2744 ), which significantly expands the state’s existing drug pricing activities with serious implications for all drug manufacturers, and particularly generic drug manufacturers. We address each below. Best price?

article thumbnail

I Hear You Knockin’… Preparing for and Managing DEA Inspections (Part 2)

FDA Law

We are providing a post in three parts on cyclic and on-site inspections in which we focus on the background of inspections, how investigators conduct them, and how registrants should proactively prepare for and manage them.